{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:19:13Z","timestamp":1790817553920,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"IRCCS Santa Lucia"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jneuroim.2015.08.016","type":"journal-article","created":{"date-parts":[[2015,8,29]],"date-time":"2015-08-29T18:41:32Z","timestamp":1440873692000},"page":"80-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Role of inflammation and apoptosis in multiple sclerosis: Comparative analysis between the periphery and the central nervous system"],"prefix":"10.1016","volume":"287","author":[{"given":"Beatrice","family":"Macchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Marino-Merlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Nocentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1570-3502","authenticated-orcid":false,"given":"Valerio","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cuzzocrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Grelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mastino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2015.08.016_bb0005","first-page":"1221","article-title":"Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis","volume":"11","author":"Babij","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0010","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.20016","article-title":"Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion","volume":"55","author":"Barnett","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0015","doi-asserted-by":"crossref","first-page":"e39576","DOI":"10.1371\/journal.pone.0039576","article-title":"Activated human CD4+CD45RO+ memory T-cells indirectly inhibit NLRP3 inflammasome activation through downregulation of P2X7R signalling","volume":"7","author":"Beynon","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0020","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jnr.10408","article-title":"Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels","volume":"70","author":"Calabrese","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ana.23606","article-title":"Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination","volume":"72","author":"Caprariello","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nm.3411","article-title":"Regulatory T cell proliferative potential is impaired in human autoimmune disease","volume":"20","author":"Carbone","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0035","doi-asserted-by":"crossref","first-page":"e66308","DOI":"10.1371\/journal.pone.0066308","article-title":"Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review","volume":"8","author":"Castillo-Trivino","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0040","doi-asserted-by":"crossref","first-page":"e1741","DOI":"10.1038\/cddis.2015.100","article-title":"FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients","volume":"6","author":"Cencioni","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0045","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1093\/brain\/aws189","article-title":"Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis","volume":"135","author":"Choi","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0050","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1212\/WNL.55.7.921","article-title":"Defective T cell Fas function in patients with multiple sclerosis","volume":"55","author":"Comi","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0055","doi-asserted-by":"crossref","first-page":"11064","DOI":"10.1073\/pnas.0402455101","article-title":"Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis","volume":"101","author":"Corcione","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1586\/17512433.2014.865517","article-title":"Novel therapeutic options for multiple sclerosis","volume":"7","author":"Curtin","year":"2014","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0065","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0165-5728(02)00056-5","article-title":"Production of IL-1beta and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis","volume":"126","author":"de Jong","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0070","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/ni.1798","article-title":"MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis","volume":"10","author":"Du","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0075","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.4049\/jimmunol.178.10.6092","article-title":"Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis","volume":"178","author":"Duddy","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0080","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.21652","article-title":"T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta","volume":"65","author":"Durelli","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0085","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/brain\/aws012","article-title":"NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury","volume":"135","author":"Fischer","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0090","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/jnr.20995","article-title":"pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity","volume":"84","author":"Frisullo","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0095","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jneuroim.2012.07.014","article-title":"The switch between relapse and remission in multiple sclerosis: continuous inflammatory response balanced by Th1 suppression and neurotrophic factors","volume":"252","author":"Gurevich","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2015.02.006","article-title":"Analysis of apoptosis-related genes in patients with clinically isolated syndrome and their association with conversion to multiple sclerosis","volume":"280","author":"Hagman","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0110","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/brain\/awr128","article-title":"Oxidative damage in multiple sclerosis lesions","volume":"134","author":"Haider","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0115","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing-remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0120","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/1352458507087468","article-title":"Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination","volume":"14","author":"Hebb","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0125","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ana.21800","article-title":"Multiple sclerosis: distribution of inflammatory cells in newly forming lesions","volume":"66","author":"Henderson","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0130","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.4049\/jimmunol.166.2.1314","article-title":"Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis","volume":"166","author":"Hilliard","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0135","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jneuroim.2013.06.007","article-title":"Biased Treg\/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms","volume":"262","author":"Jamshidian","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0140","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40263-015-0251-1","article-title":"Platform therapy compared with natalizumab for multiple sclerosis: relapse rates and time to relapse among propensity score-matched US patients","volume":"29","author":"Johnson","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0145","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.clim.2009.08.012","article-title":"Differential susceptibility to apoptosis of CD4+T cells expressing CCR5 and CXCR3 in patients with MS","volume":"133","author":"Julia","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0150","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/biof.1156","article-title":"Toll-like receptors: role in inflammation and therapeutic potential","volume":"40","author":"Kay","year":"2014","journal-title":"Biofactors"},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0155","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2011.08.019","article-title":"Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive\/memory Breg ratio during a relapse but not in remission","volume":"239","author":"Knippenberg","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0160","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/brain\/awh641","article-title":"Cortical demyelination and diffuse white matter injury in multiple sclerosis","volume":"128","author":"Kutzelnigg","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0165","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3109\/08830185.2013.823422","article-title":"Role of pathogens in multiple sclerosis","volume":"33","author":"Libbey","year":"2014","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0170","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.1523\/JNEUROSCI.1636-12.2013","article-title":"Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis","volume":"33","author":"Lin","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2012.02.015","article-title":"Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro","volume":"246","author":"Lisak","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0180","unstructured":"Liu, T., Ji, R.R., 2014. Toll-Like Receptors and Itch. Itch: Mechanisms and Treatment. 2014 by Taylor & Francis Group, LLC.: Boca Raton FL."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021766","article-title":"TRAIL\/TRAIL receptor system and susceptibility to multiple sclerosis","volume":"6","author":"Lopez-Gomez","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0190","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0195","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0200","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00001756-199902050-00034","article-title":"Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis","volume":"10","author":"Macchi","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0205","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1097\/00001756-200112210-00050","article-title":"Defective Fas ligand productions in lymphocytes from MS patients","volume":"12","author":"Macchi","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0210","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/brain\/awn105","article-title":"Mitochondrial defects in acute multiple sclerosis lesions","volume":"131","author":"Mahad","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0215","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2011.12.026","article-title":"Aberrant expression of the apoptosis-related proteins BAK and MCL1 in T cells in multiple sclerosis","volume":"244","author":"Mandel","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0220","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.clim.2012.12.006","article-title":"Specific inflammasomes in complex diseases","volume":"147","author":"Masters","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0225","doi-asserted-by":"crossref","first-page":"7646","DOI":"10.4049\/jimmunol.1000930","article-title":"Oligodendrocyte-specific FADD deletion protects mice from autoimmune-mediated demyelination","volume":"185","author":"Mc Guire","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0230","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/ana.24163","article-title":"Pathologic heterogeneity persists in early active multiple sclerosis lesions","volume":"75","author":"Metz","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0235","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fimmu.2014.00079","article-title":"TLR agonists as modulators of the innate immune response and their potential as agents against infectious disease","volume":"5","author":"Mifsud","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0240","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2007.10.022","article-title":"Inhibitor of apoptosis protein (IAP) profiling in experimental autoimmune encephalomyelitis (EAE) implicates increased XIAP in T lymphocytes","volume":"193","author":"Moore","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0245","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2014.04.007","article-title":"Activation-induced cell death in T lymphocytes from multiple sclerosis patients","volume":"272","author":"Moreno","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0250","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jneuroim.2013.07.013","article-title":"Circulating levels of soluble apoptosis-related molecules in patients with multiple sclerosis","volume":"263","author":"Moreno","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0255","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1517\/13543776.2015.1043267","article-title":"Novel diagnostic tools and solutions for multiple sclerosis treatment: a patent review (2009\u20132014)","volume":"25","author":"Papini","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0260","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.molimm.2014.10.008","article-title":"Increased inflammasome related gene expression profile in PBMC may facilitate T helper 17 cell induction in multiple sclerosis","volume":"63","author":"Peelen","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0265","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.bcp.2011.07.092","article-title":"Redox regulation of cellular stress response in multiple sclerosis","volume":"82","author":"Pennisi","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0270","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/archneurol.2010.99","article-title":"Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis","volume":"67","author":"Piccio","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0275","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1089\/jir.2014.0020","article-title":"Is T-bet a potential therapeutic target in multiple sclerosis?","volume":"34","author":"Racke","year":"2014","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0280","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000356522","article-title":"FADD is upregulated in relapsing remitting multiple sclerosis","volume":"21","author":"Reuss","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0285","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jneuroim.2008.09.002","article-title":"Apoptosis-related molecules in blood in multiple sclerosis","volume":"205","author":"Rinta","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0290","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.clim.2013.10.012","article-title":"Toll-like receptor 3 differently modulates inflammation in progressive or benign multiple sclerosis","volume":"150","author":"Saresella","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0295","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/2013.jamaneurol.409","article-title":"Enriched CD161high CCR6+ gammadelta T cells in the cerebrospinal fluid of patients with multiple sclerosis","volume":"70","author":"Schirmer","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0300","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0165-5728(00)00443-4","article-title":"Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis","volume":"113","author":"Semra","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0305","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(02)00024-3","article-title":"The expression of pro- and anti-apoptosis Bcl-2 family proteins in lymphocytes from patients with multiple sclerosis","volume":"125","author":"Sharief","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0310","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1177\/1352458515574896","article-title":"The role of epidemiology in MS research: Past successes, current challenges and future potential","volume":"21","author":"Simpson","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0315","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1126\/science.1065543","article-title":"Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells","volume":"295","author":"Szabo","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0320","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","article-title":"Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis","volume":"172","author":"Tzartos","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0325","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2990.2000.00217.x","article-title":"Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS","volume":"26","author":"van der Valk","year":"2000","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0330","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1742-2094-9-156","article-title":"Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation","volume":"9","author":"van Horssen","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0335","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2174\/187152712801661293","article-title":"Mechanisms in the development of multiple sclerosis lesions: reconciling autoimmune and neurodegenerative factors","volume":"11","author":"van Noort","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0340","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jneuroim.2010.05.025","article-title":"Memory CD4+CD127high T cells from patients with multiple sclerosis produce IL-17 in response to myelin antigens","volume":"226","author":"Venken","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0345","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/brain\/awp337","article-title":"Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death","volume":"133","author":"Veto","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0350","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1172\/JCI63842","article-title":"B cell exchange across the blood\u2013brain barrier in multiple sclerosis","volume":"122","author":"von Budingen","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0355","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0165-5728(02)00067-X","article-title":"Elevated Bcl-X-L levels correlate with T cell survival in multiple sclerosis","volume":"126","author":"Waiczies","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0360","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pathophys.2009.10.007","article-title":"Pathophysiology of the lymphatic drainage of the central nervous system: implications for pathogenesis and therapy of multiple sclerosis","volume":"17","author":"Weller","year":"2010","journal-title":"Pathophysiology"},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0365","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1073\/pnas.89.10.4588","article-title":"Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions","volume":"89","author":"Wucherpfennig","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0370","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1479-5876-11-107","article-title":"Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer","volume":"11","author":"Yang","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jneuroim.2015.08.016_bb0375","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1742-2094-9-173","article-title":"CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species","volume":"9","author":"Yeo","year":"2012","journal-title":"J. Neuroinflammation"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572815300357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572815300357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:26:28Z","timestamp":1759047988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572815300357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":75,"alternative-id":["S0165572815300357"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.08.016","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of inflammation and apoptosis in multiple sclerosis: Comparative analysis between the periphery and the central nervous system","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}